These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23761319)

  • 1. The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy.
    Panay N; Hamoda H; Arya R; Savvas M;
    Menopause Int; 2013 Jun; 19(2):59-68. PubMed ID: 23761319
    [No Abstract]   [Full Text] [Related]  

  • 2. The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women.
    Hamoda H; Panay N; Pedder H; Arya R; Savvas M
    Post Reprod Health; 2020 Dec; 26(4):181-209. PubMed ID: 33045914
    [No Abstract]   [Full Text] [Related]  

  • 3. Modernizing the NHS: observations and recommendations from the British Menopause Society.
    British Menopause Society Council
    Menopause Int; 2011 Jun; 17(2):41-3. PubMed ID: 21693497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 5. At third meeting, menopause experts make the most of insufficient data.
    Skolnick AA
    JAMA; 1992 Nov; 268(18):2483-5. PubMed ID: 1404808
    [No Abstract]   [Full Text] [Related]  

  • 6. Menopausal hormone therapy and national time trends in mortality: cautions regarding causal inference.
    Manson JE; Bassuk SS; Merz CNB; Kaunitz AM
    Menopause; 2017 Aug; 24(8):874-876. PubMed ID: 28486245
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 8. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopause. A flash of concern.
    Wingert P
    Newsweek; 2007 Apr; 149(16):16. PubMed ID: 17477154
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy.
    Pitkin J; Rees MC; Gray S; Lumsden MA; Marsden J; Stevenson J; Williamson J;
    J Br Menopause Soc; 2005 Dec; 11(4):152-6. PubMed ID: 16354459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decade after the Women's Health Initiative--the experts do agree.
    Stuenkel CA; Gass ML; Manson JE; Lobo RA; Pal L; Rebar RW; Hall JE
    Menopause; 2012 Aug; 19(8):846-7. PubMed ID: 22776849
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy for menopausal symptoms.
    Roberts H
    BMJ; 2012 Feb; 344():e815. PubMed ID: 22318438
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
    Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 16. Re-think HRT: behind the scene of perceptions.
    Pines A
    Climacteric; 2008; 11(6):443-6. PubMed ID: 18991073
    [No Abstract]   [Full Text] [Related]  

  • 17. [Should estrogen replacement therapy be questioned?].
    Tiitinen A
    Duodecim; 2000; 116(16):1669-71. PubMed ID: 12001440
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks and benefits of hormone replacement therapy, revisited. An update on the Women's Health Initiative study, which in 2002 changed the landscape of hormone replacement therapy.
    Duke Med Health News; 2014 Jan; 20(1):5-6. PubMed ID: 25632509
    [No Abstract]   [Full Text] [Related]  

  • 19. What a surprise.
    Freda MC
    MCN Am J Matern Child Nurs; 2007; 32(3):137. PubMed ID: 17479045
    [No Abstract]   [Full Text] [Related]  

  • 20. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.